1. Home
  2. Labeler Index
  3. Aurobindo Pharma Limited
  4. 59651-740
  5. NDC Package Code: 59651-740-92 Rhuzdah

NDC Package 59651-740-92 Rhuzdah

Norethindrone And Ethinyl Estradiol Tablet Kit - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
59651-740-92
Package Description:
6 POUCH in 1 CARTON / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK
Product Code:
59651-740
Proprietary Name:
Rhuzdah
Non-Proprietary Name:
Norethindrone And Ethinyl Estradiol Tablet
Usage Information:
Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptives are highly effective. Table 1 lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates.TABLE 1 LOWEST EXPECTED AND TYPICAL FAILURE RATES DURING THE FIRST YEAR OF CONTINUOUS USE OF A METHOD Reproduced with permission of the Population Council from J. Trussell, et. al: Contraceptive failure in the United States: An update. Studies in Family Planning, 21(1), January-February 1990.*The authors’ best guess of the percentage of women expected to experience an accidental pregnancy among couples who initiate a method (not necessarily for the first time) and who use it consistently and correctly during the first year if they do not stop for any reason other than pregnancy.**This term represents “typical” couples who initiate use of a method (not necessarily for the first time), who experience an accidental pregnancy during the first year if they do not stop use for any reason other than pregnancy.***Combined typical rate for both combined and progestin only.#Combined typical rate for both medicated and nonmedicated IUD. % of Women Experiencing an Accidental Pregnancy in the First Year of Continuous Use MethodLowest Expected*Typical** (No contraception) Oral contraceptives     combined     progestin only Diaphragm with spermicidal cream or jelly Spermicides alone (foam, creams, jellies and vaginal suppositories) Vaginal sponge     nulliparous     multiparous IUD Condom without spermicides Periodic abstinence (all methods) Injectable progestogen Implants     6 capsules     2 rods Female sterilization Male sterilization(85) 0.10.563 690.8 to 221 to 90.3 to 0.4 0.040.030.20.1(85) 3***3***1821 18283#12200.3 to 0.4 0.040.030.40.15
11-Digit NDC Billing Format:
59651074092
NDC to RxNorm Crosswalk:
  • RxCUI: 238015 - norethindrone 0.4 MG / ethinyl estradiol 0.035 MG Oral Tablet
  • RxCUI: 238015 - ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Oral Tablet
  • RxCUI: 2624207 - {21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Rhuzdah 28 Day]
  • RxCUI: 2624207 - Rhuzdah 28 Day Pack
  • RxCUI: 748797 - inert 1 MG Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Aurobindo Pharma Limited
    Dosage Form:
    Kit - A packaged collection of related material.
    Sample Package:
    No
    FDA Application Number:
    ANDA207585
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    10-11-2022
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    59651-740-883 POUCH in 1 CARTON / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 59651-740-92?

    The NDC Packaged Code 59651-740-92 is assigned to a package of 6 pouch in 1 carton / 1 blister pack in 1 pouch / 1 kit in 1 blister pack of Rhuzdah, a human prescription drug labeled by Aurobindo Pharma Limited. The product's dosage form is kit and is administered via form.

    Is NDC 59651-740 included in the NDC Directory?

    Yes, Rhuzdah with product code 59651-740 is active and included in the NDC Directory. The product was first marketed by Aurobindo Pharma Limited on October 11, 2022 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 59651-740-92?

    The 11-digit format is 59651074092. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-259651-740-925-4-259651-0740-92